There's an irony at the heart of NeoStrata's story. The brand that brought alpha hydroxy acids to the world — whose founders literally invented the category — eventually concluded that their own flagship ingredient was too harsh for millions of the people who needed it. Sensitive skin, rosacea, post-procedure recovery: an enormous population wanted the anti-aging benefits of acid exfoliation and could not tolerate the sting, redness and photosensitivity that traditional AHAs delivered alongside them.
The answer was polyhydroxy acids. The Bionic Face Cream, with its 12% blend of gluconolactone and lactobionic acid, is what that answer looks like after more than a decade of refinement.
The first thing you notice is the texture. This is not a lightweight modern gel-cream. It's a rich, almost balm-like emollient that initially reads closer to a medicated ointment than a fashionable moisturizer. Apply it to slightly damp skin — genuinely important for spreading — and it transforms from thick paste into a smooth velvety layer that sinks in over several minutes, leaving a dewy finish substantial enough that you instinctively touch your face to confirm something happened.
What's happening underneath is where it gets interesting. Gluconolactone, the primary PHA at 8%, exfoliates through the same fundamental mechanism as glycolic acid — loosening the bonds between dead corneocytes. But its molecule is dramatically larger: 178 g/mol against glycolic acid's 76. That size means it penetrates more slowly and far more uniformly, which is the entire reason it delivers real exfoliation without the sting, the flush, or the peeling that smaller acids provoke. Gentleness here is a function of physics, not of a weaker dose.
And gluconolactone does two things glycolic acid simply cannot. Its polyhydroxy structure — multiple hydroxyl groups per molecule — lets it act as a humectant *while* it exfoliates, drawing moisture to the surface during the very process that would normally dry skin out. It also chelates transition metal ions like iron and copper, suppressing the Fenton-reaction free radicals that drive oxidative aging. Exfoliation, hydration and antioxidant defense from a single molecule. That trio is why the people who invented AHAs regard PHAs as a genuine advance on their own work.
Lactobionic acid, the second PHA at 4%, extends the idea further. Its disaccharide structure binds water and quenches radicals even more effectively — this is, remarkably, the same molecule used in organ preservation solutions to protect donated tissue from oxidative damage in transit. On skin it forms a protective, moisture-retaining film that feels like luxury hydration while quietly doing anti-aging work.
The supporting cast reinforces the theme relentlessly. Sodium hyaluronate hydrates within the epidermis. Meadowfoam seed oil contributes long-chain fatty acids that mirror the skin's own lipids. Petrolatum and dimethicone build an occlusive shield. Glycerin handles classic humectancy. The whole formula is engineered to exfoliate inside a cocoon of moisture — the exact inverse of the stripping experience most people associate with acids.
In use, the reputation is earned. There is genuinely no tingle, even on the first application. For anyone who has ever braced themselves before applying a glycolic product, a cream carrying 12% acid that does nothing at all on contact feels faintly implausible. Within two to four weeks the exfoliation becomes visible: smoother texture, better radiance, a refinement you can both see and feel. By six weeks, fine lines soften and skin looks more resilient.
Rosacea sufferers deserve particular mention. Long-term users repeatedly report that this cream not only fails to trigger flares but actively reduces background redness over time. For a population accustomed to scrutinizing every label for hidden provocations, finding an acid cream that is not merely safe but *beneficial* is genuinely rare — and it's why this product occupies a permanent shelf position in so many bathrooms.
A myth worth killing: PHAs are not weak AHAs. Published work shows comparable improvements in fine lines, texture and firmness at equivalent concentrations, with markedly less sensory irritation. What changed was the delivery, not the outcome. And despite the emollient richness, the cream is certified non-comedogenic — the PHA-driven turnover actually works against the dead-cell buildup that clogs pores in the first place.
The honest downsides are practical rather than formulary. Sixty-six dollars for 1.4 oz — six to eight weeks of twice-daily use — is a steep per-ounce cost. The rich texture, wonderful at night, pills under makeup and primer, which limits daytime usefulness for a lot of people. And the jar contains Yellow 5 and Red 33, colorants that give it a faint pink tint and serve no purpose whatsoever, which is a strange thing to find in a fragrance-free clinical product aimed at reactive skin. Oily skin will find it far too heavy regardless.
One genuine advantage over AHAs is worth stating plainly: PHAs do not increase photosensitivity, which removes an entire category of risk from the routine.
For its intended audience — dry, sensitive, aging or rosacea-prone skin that wants the proven benefits of acid exfoliation without the proven costs — this cream is something close to unique. It's the product that proved acid skincare doesn't have to hurt in order to work, made by the only brand that earned the right to make that claim.
